COLORADO SPRINGS, CO--(Marketwired - Apr 6, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today acknowledges and is very excited about the Landmark move with the Drug Enforcement Agency's (DEA) decision to review marijuana's federal drug classification as early as mid-2016. Rescheduling marijuana would ease restrictions on research across the country, while at the same time reducing penalties for marijuana offenses. Increased research capabilities could spur innovation and growth in the cannabis industry.

To review the Huffington Post article please click here to read the article in its entirety.

In a letter to the Senators; http://big.assets.huffingtonpost.com/dearesponse.pdf the Drug Enforcement Administration (DEA) is looking to decide on the reclassification of Marijuana by mid-year.

For years, marijuana has shared the "Schedule I" classification with heroin and LSD, drugs with much higher rates of death and hospitalization for users. This classification also specifies the drug has no "current accepted medical use". Cannabis Science, along with the masses, believe this has changed emphatically, based on the many ground-breaking university and private studies along with the ever growing long list of peer reviewed articles.

"We are very pleased to hear the DEA's decision to review marijuana's drug classification scheduling. It is clear to us and to so many others that the natural drug offers a host of health benefits and treatment properties. Cannabis Science will benefit extraordinarily as our research is already on the cutting edge, this Landmark move will open the industry in leaps and bounds," said Cannabis Science Inc. President, CEO & Co-Founder Raymond C. Dabney.

The DEA hopes to publish its decision in the first half of 2016. This decision is becoming increasingly important as more states decide to legalize cannabis for medicinal use. Nearly half of the U.S. states have already made such a decision, and a schedule change would have positive benefits for each of them.